Barbara Bodem

Barbara W.
Bodem is currently Director at DJO Global, Inc., Independent Director at Enovis Corp., Independent Director at BioMarin Pharmaceutical, Inc., Director at NorthStar Medical Radioisotopes LLC, Independent Director at Option Care Health, Inc., Co-President & Director at Hill ROM Co, Inc., and Director at BiomEdit, Inc. Former positions include Independent Director at Invacare Corp., Independent Director at Turning Point Therapeutics, Inc., Independent Director at Syneos Health, Inc., Chief Financial Officer & Senior Vice President at Hill-Rom Holdings, Inc., Principal at Eli Lilly & Co., Vice President-Global Commercial Finance at Hospira, Inc., Senior Vice President-Finance at Keenova Therapeutics Plc, Chief Financial Officer at Lilly Oncology, and Chief Financial Officer at Dentsply Sirona, Inc. Education includes undergraduate and MBAistration degrees from Indiana University.